PDF herunterladen
Aktuelle Dermatologie 2011; 37(8/09): 317-332
DOI: 10.1055/s-0030-1256728
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Graft-versus-Host-Erkrankung der Haut

Graft-versus-Host-Disease of the SkinU.  Hillen1
  • 1
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. August 2011 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Lernziele

Kenntnisse über:

Klassifikation und Grading der Graft-versus-Host-Erkrankung (GvHD) Organmanifestationen Klinik der kutanen GvHD Diagnostik der kutanen GvHD nach NIH-Konsensus Therapie der kutanen GvHD

Literatur

  • 1 Hertenstein B, Ganser A. Knochenmarktransplantation.  Internist. 2004;  45 1261-1267
    CrossrefPubMedSuche in Google Scholar
  • 2 Deutsches Register für Stammzelltransplantation. Jahresbericht 2009. Im Internet: http://www.drst.de/jb.html Stand 11.08.2010
  • 3 Buchholz S, Ganser A. Hämatopoetische Stammzelltransplantation.  Internist. 2009;  50 572-580
    CrossrefPubMedSuche in Google Scholar
  • 4 Billingham R E. The biology of graft-versus-host reactions.  Harvey Lect. 1966–1967;  62 21-78
    PubMedSuche in Google Scholar
  • 5 Ringdén O, Karlsson H, Olsson R et al. The allogeneic graft-versus-cancer effect.  Br J Haematol. 2009;  147 614-633
    CrossrefPubMedSuche in Google Scholar
  • 6 Ferrara J LM, Levine J E, Reddy P et al. Graft-versus-host disease.  Lancet. 2009;  373 1550-1561
    CrossrefPubMedSuche in Google Scholar
  • 7 Shlomchik W D. Graft-versus-host disease.  Nat Rev Immunol. 2007;  7 340-352
    CrossrefPubMedSuche in Google Scholar
  • 8 Beelen D W, Haralambie E, Brandt H et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.  Blood. 1992;  80 2668-2676
    PubMedSuche in Google Scholar
  • 9 Penack O, Holler E, van den Brink M R. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors.  Blood. 2010;  115 1865-1872
    CrossrefPubMedSuche in Google Scholar
  • 10 Leung A Y, Kwong Y L. Haematopoetic stem cell transplantation: current concepts and novel therapeutic strategies.  Br Med Bull. 2010;  93 85-103
    CrossrefPubMedSuche in Google Scholar
  • 11 Ball L M, Egeler R M EBMT Paediatric Working Party. Acute GvHD: pathogenesis and classification.  Bone Marrow Transplant. 2008;  41 (Suppl. 2) 58-64
    CrossrefPubMedSuche in Google Scholar
  • 12 Martin P J. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.  Keio J Med. 2008;  57 177-183
    CrossrefPubMedSuche in Google Scholar
  • 13 Lee J W, Deeg J H. Prevention of chronic GVHD.  Best Pract Res Clin Haematol. 2008;  21 259-270
    CrossrefPubMedSuche in Google Scholar
  • 14 Shimabukuro-Vornhagen A, Hallek M J, Storb R F et al. The role of B cells in the pathogenesis of graft-versus-host disease.  Blood. 2009;  114 4919-4927
    CrossrefPubMedSuche in Google Scholar
  • 15 Svegliati S, Olivieri A, Campelli N et al. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.  Blood. 2007;  110 237-241
    CrossrefPubMedSuche in Google Scholar
  • 16 Kim S J, Lee J W, Jung C W et al. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study.  Haematologica. 2010;  95 1935-1942
    CrossrefPubMedSuche in Google Scholar
  • 17 Rieger K, Loddenkemper C, Maul J et al. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.  Blood. 2006;  107 1717-1723
    CrossrefPubMedSuche in Google Scholar
  • 18 Hoffmann P, Ermann J, Edinger M et al. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.  J Exp Med. 2002;  196 389-399
    CrossrefPubMedSuche in Google Scholar
  • 19 Pidala J, Anasetti C. Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?.  Haematologica. 2010;  95 660-665
    CrossrefPubMedSuche in Google Scholar
  • 20 Filipovich A H, Weisdorf D, Pavletic S et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.  Biol Blood Marrow Transplant. 2005;  11 945-956
    CrossrefPubMedSuche in Google Scholar
  • 21 Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.  Transplantation. 1974;  18 295-304
    CrossrefPubMedSuche in Google Scholar
  • 22 Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading.  Bone Marrow Transplant. 1995;  15 825-828
    PubMedSuche in Google Scholar
  • 23 Cahn J Y, Klein J P, Lee S J et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.  Blood. 2005;  106 1495-1500
    CrossrefPubMedSuche in Google Scholar
  • 24 Socié G, Stone J V, Wingard J R et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.  N Engl J Med. 1999;  341 14-21
    CrossrefPubMedSuche in Google Scholar
  • 25 Joseph R W, Couriel D R, Komanduri K V. Chronic Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation: Challenges in Prevention, Science, and Supportive Care.  J Support Oncol. 2008;  6 361-372
    PubMedSuche in Google Scholar
  • 26 Lee S J, Flowers M ED. Recognizing and Managing Chronic Graft-Versus-Host Disease.  Hematology Am Soc Hematol Educ Program. 2008;  1 134-141
    PubMedSuche in Google Scholar
  • 27 Baker K S, Fraser C J. Quality of life and recovery after graft-versus-host disease.  Best Pract Res Clin Haematol. 2008;  21 333-341
    CrossrefPubMedSuche in Google Scholar
  • 28 Hymes S R, Turner M L, Champlin R E et al. Cutaneous Manifestations of Chronic Graft-versus-Host Disease.  Biol Blood Marrow Transplant. 2006;  12 1101-1113
    CrossrefPubMedSuche in Google Scholar
  • 29 Lerner K G, Kao G F, Storb R et al. Histopathology of graft-versus-host reaction (GVHR) in human recipients of marrow from HL-A matched sibling donors.  Transplant Proc. 1974;  6 367-371
    PubMedSuche in Google Scholar
  • 30 Shulman H M, Kleiner D, Lee S J et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.  Biol Blood Marrow Transplant. 2006;  12 31-47
    PubMedSuche in Google Scholar
  • 31 Apperley J, Carreras E, Gluckman E et al. eds. The EBMT-ESH Handbook on Haematopoietic stem cell transplantation. 5th ed. 2008 Im Internet: http://www.ebmt.org/EBMT_Handbook.html
    Suche in Google Scholar
  • 32 Deeg H J. How I treat refractory acute GVHD.  Blood. 2007;  109 4119-4126
    CrossrefPubMedSuche in Google Scholar
  • 33 Paczesny S, Choi S W, Ferrara J L. Acute graft-versus-host disease: new treatment strategies.  Curr Opin Hematol. 2009;  16 427-436
    CrossrefPubMedSuche in Google Scholar
  • 34 Furlong T, Leisenring W, Storb R et al. Psoralen and Ultraviolet A Irradiation (PUVA) as Therapy for Steroid-Resistant Cutaneous Acute Graft-versus-Host Disease.  Biol Blood Marrow Transplant. 2002;  8 206-212
    CrossrefPubMedSuche in Google Scholar
  • 35 Schlaak M, Schwind S, Wetzig T et al. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin.  Bone Marrow Transplant. 2010;  45 1741-1748
    CrossrefPubMedSuche in Google Scholar
  • 36 Greinix H T, Knobler R M, Worel N et al. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.  Haematologica. 2006;  91 405-408
    PubMedSuche in Google Scholar
  • 37 Greinix H T, Worel N, Knobler R. Role of Extracorporeal Photopheresis (ECP) in treatment of steroidrefractory acute graft-versus-host disease.  Biol Blood Marrow Transplant. 2010;  16 1747-1748
    CrossrefPubMedSuche in Google Scholar
  • 38 Jagasia M, Giglia J, Chinratanalab W et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.  Biol Blood Marrow Transplant. 2007;  13 1207-1215
    CrossrefPubMedSuche in Google Scholar
  • 39 Cho B S, Min C K, Eom K S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.  Leukemia. 2009;  23 78-84
    CrossrefPubMedSuche in Google Scholar
  • 40 Wolff D, Gerbitz A, Ayuk F et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): First-line and topical treatment of chronic GVHD.  Biol Blood Marrow Transplant. 2010;  16 1611-1628
    CrossrefPubMedSuche in Google Scholar
  • 41 Elad S, Or R, Resnick I, Shapira M Y. Topical tacrolimus – a novel treatment alternative for cutaneous chronic graft-versus-host disease.  Transpl Int. 2003;  16 665-670
    PubMedSuche in Google Scholar
  • 42 Choi C J, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.  Arch Dermatol. 2001;  137 1202-1206
    PubMedSuche in Google Scholar
  • 43 Koc S, Leisenring W, Flowers M E et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.  Blood. 2002;  100 48-51
    CrossrefPubMedSuche in Google Scholar
  • 44 Wolff D, Schleuning M, von Harsdorf S et al. Consensus conference on clinical practice in chronic GVHD: Second-Line Treatment of chronic Graft-versus-Host Disease.  Biol Blood Marrow Transplant. 2011;  17 1-17
    CrossrefPubMedSuche in Google Scholar
  • 45 Couriel D R, Hosing C, Saliba R et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.  Blood. 2006;  107 3074-3080
    CrossrefPubMedSuche in Google Scholar
  • 46 Flowers M E, Apperley J F, van Besien K et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.  Blood. 2008;  112 2667-2674
    CrossrefPubMedSuche in Google Scholar

PD Dr. Uwe Hillen

Klinik für Dermatologie
Universitätsklinikum Essen

Hufelandstr. 55
45147 Essen

eMail: uwe.hillen@uk-essen.de